Teva Stock: Wait And See On This Stock (NYSE:TEVA) | Seeking Alpha
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
DOJ accuses drugmaker Teva of illegal kickbacks to inflate prices | Fox Business
Teva & Allergan Settle WV Opioid Lawsuit For Over $160 Million | MedTruth - Prescription Drug & Medical Device Safety | Informed Advocacy
Drug Companies Teva, Allergan Ready to Pay $5 Billion to Resolve Opioid Suits - Bloomberg
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Teva to Pay $420M to Settle Shareholders' Generic Drug Pricing Lawsuit — Report - TipRanks.com
Texas settles another opioid lawsuit, wins $225 million against Teva
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva drops lawsuit with Amicus over Creates Act dispute
New York Jury Finds Drugmaker Teva Liable for Fueling Opioid Crisis
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva agrees to $4.35B settlement to end opioid lawsuits - Top Class Actions
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva agrees to $4.25 billion settlement in opioid lawsuit
Opioid Lawsuit Against Teva Pharma
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva Pharmaceuticals will pay $420 million in a federal case
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Teva CEO says company could pay up to $3.6B to put opioid litigation to bed: report | Fierce Pharma
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
